Morningstar Investor users sign in here.

Stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Mentioned: Amazon.com Inc (AMZN), Berkshire Hathaway Inc (BRK.A), Berkshire Hathaway Inc (BRK.B), The Kraft Heinz Co (KHC), Teva Pharmaceutical Industries Ltd (TEVA), Wells Fargo & Co (WFC)


Last week, Berkshire Hathaway (BRK.B) (BRK.A) released its second-quarter 13-F. The investment manager is required to report its consolidated equity investments in quarterly filings with the US Securities and Exchange Commission.

Morningstar's resident Berkshire specialist Gregg Warren noted that Berkshire was a net seller of equities during the quarter. We think most of Berkshire's holdings are fairly to overvalued today--including the names the firm added to last quarter. But there are four names that weren't trimmed during the quarter that we still think are undervalued today.

Here are our analysts' latest stock takes:

Amazon.com

  • Current Morningstar Rating (as of Aug. 20): 4 stars
  • Economic Moat Rating: Wide

"Wide-moat Amazon reported second-quarter results that were within its guidance range but were slightly short of investor expectations for both revenue and operating profit. Guidance for the third quarter is also light compared with FactSet consensus. In short, consumers' online shopping levels are returning to more normal levels as they shift some spending to other entertainment sources and offline shopping.

Meanwhile, the company continues to add capacity at a breakneck pace in order to meet customer demand and one-day delivery, even as it roughly doubled its footprint during the past 18 months. We see no cracks in the long-term story as Amazon remains well-positioned to prosper from the secular shift toward e-commerce and the public cloud over the next decade.

We note revenue weakness was limited to Amazon's own online store segment, with other segments performing well and overall profitability impressive despite lower revenue. Our model changes are fairly modest, thus we are maintaining our US$4,200 per share fair value estimate and see shares as undervalued.

Third-party seller services grew 38% year over year despite a marked slowdown, as the solution remains attractive to merchants. Subscription services, AWS, and other remained strong, with year-over-year growth of 32%, 37%, and 88%, respectively.

We continue to view advertising (in 'other') and AWS as key long-term growth drivers for the firm. In particular we see AWS as the clear leader in public cloud, and we think Amazon's advertising business offers a unique value proposition for marketers.

-Dan Romanoff, analyst

Kraft Heinz

  • Current Morningstar Rating (as of Aug. 20): 4 stars
  • Economic Moat Rating: None

"While Kraft Heinz's organic sales slumped 2.1% in the second quarter, we don't think this modest pullback precipitated the 4% downdraft in shares. Rather, we think the market is souring on the no-moat name given its thirst for transparency isn't being quenched, with management reluctant to provide annual guidance beyond its long-term targets for 1%-2% organic sales growth and 4%-6% adjusted EPS growth (which match our outlook).

"But from our vantage point, the results illustrate the revised strategic playbook Kraft Heinz has been operating under since CEO Miguel Patricio took the helm two years ago is yielding marked performance improvements. In this context, organic sales were up 5% in the second quarter on a two-year stack for both the consolidated organization and its core U.S hub (about 70% of total sales).

But more impressive, this growth hasn't been met wit an erosion in profitability or investment in the business, as adjusted operating margins are up 140 basis points relative to the same period in 2019 even as marketing spend is up more than 10%. Also, the firm is continuing to realise increased relevance with consumers, with management citing that household penetration (up nearly 3%, equating to nearly 2 million more households), repeat purchases (up more than 8%), spending per buyer (up around 10%), and spending per trip (up 3%) are each edging higher since its revamped road map was put in place.

"Against this backdrop, we think shares offer an attractive entry point, trading at a 25% discount to our fair value estimate."

-Erin Lash, director

Teva Pharmaceutical

  • Current Morningstar Rating (as of Aug. 20): 4 stars
  • Economic Moat Rating: None

"Teva posted moderate results this quarter, with revenue essentially flat and margins within our expected range. Despite middling sales, the company continued to reduce debt and may receive terms that dampen the severity of its eventual settlement in the opioid litigation. We maintain our fair value estimate of US$20 per share and our no-moat rating.

"Revenue grew by 1% year over year but declined by 2% absent a positive currency impact. Europe sales stood out solely due to a uniquely poor comparison last year. On a sequential basis, revenue decreased by 2%, spread evenly across all main regions. This decrease was led by poor generics sales in North America, due to continued price competition in the industry.

Austedo (for Huntington's disease and tardive dyskinesia) was 9% of North America revenue this quarter, making it the company's best-selling product in the region. Austedo had a profitable launch in China this quarter, but it will remain small for at least the next few years as it gains traction."

Damien Conover, director

Wells Fargo

  • Current Morningstar Rating (as of Aug 20): 4 stars
  • Economic Moat Rating: Wide

"Wide-moat Wells Fargo reported OK second-quarter earnings. Overall, results largely fit within our projections, and after making some minor adjustments, we are increasing our fair value estimate to US$55 per share. This is primarily related to slight adjustments to credit costs and fees, and to the time value of money. We've also moved up rate hikes to late 2023 from 2025.

Wells remains our top pick among the traditional US banks, and we think it has unique, idiosyncratic upside compared with peers as more expense savings play out over 2021 and beyond, and we think the asset cap will be lifted sometime in the fourth quarter of 2021 or the first quarter of 2022. Meanwhile, we view most of the rest of our banking coverage as fully valued."

Eric Compton, senior analyst

 



© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

3 shares for income investors
Stocks

3 shares for income investors

A dividend screen is a jumping off point for further research.
What we think of Morningstar subscribers' most traded share
Stocks

What we think of Morningstar subscribers' most traded share

This stock was the second largest ‘buy’ for 2023 and was also the second largest ‘sell’ for Morningstar subscribers.
How to build an income portfolio
Stocks

How to build an income portfolio

Investors love dividends but creating an income stream involves more than just picking the highest yielding shares.
The art of buying stocks at 52-week lows
Stocks

The art of buying stocks at 52-week lows

Stock markets are highly efficient in the long run yet share prices can fluctuate wildly near term. The art of investing is buying quality stocks...
A cheap US dividend share that’s 30% undervalued and yields above 4%
Stocks

A cheap US dividend share that’s 30% undervalued and yields above 4%

Income investors: Stock up on this narrow-moat name.
This equity raise looks extremely attractive
Stocks

This equity raise looks extremely attractive

We recommend participating in the retail offer, providing it is consistent with your financial goals.